165 related articles for article (PubMed ID: 29420758)
1. Moulds associated with contaminated ocular and injectable drugs: FDA recalls, epidemiology considerations, drug shortages, and aseptic processing.
Ahearn DG; Stulting RD
Med Mycol; 2018 Jun; 56(4):389-394. PubMed ID: 29420758
[TBL] [Abstract][Full Text] [Related]
2. A review of melanized (black) fungal contamination in pharmaceutical products--incidence, drug recall and control measures.
Vijayakumar R; Saleh Al-Aboody M; Sandle T
J Appl Microbiol; 2016 Apr; 120(4):831-41. PubMed ID: 26119714
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of FDA drug recalls: A 30-month analysis.
Hall K; Stewart T; Chang J; Freeman MK
Am J Health Syst Pharm; 2016 Feb; 73(4):235-40. PubMed ID: 26843501
[TBL] [Abstract][Full Text] [Related]
4. Fungi associated with drug recalls and rare disease outbreaks.
Ahearn DG; Doyle Stulting R
J Ind Microbiol Biotechnol; 2014 Nov; 41(11):1591-7. PubMed ID: 25173741
[TBL] [Abstract][Full Text] [Related]
5. Critical Analysis of Drug Product Recalls due to Nitrosamine Impurities.
Bharate SS
J Med Chem; 2021 Mar; 64(6):2923-2936. PubMed ID: 33706513
[TBL] [Abstract][Full Text] [Related]
6. A retrospective regulatory analysis of FDA recalls carried out by pharmaceutical companies from 2012 to 2023.
Patel R; Vhora A; Jain D; Patel R; Khunt D; Patel R; Dyawanapelly S; Junnuthula V
Drug Discov Today; 2024 Jun; 29(6):103993. PubMed ID: 38670257
[TBL] [Abstract][Full Text] [Related]
7. Human Medicines Recall Announcements in Saudi Arabia Between 2017 and 2022: An Analysis of Saudi Food and Drug Authority (SFDA) Reports.
Almutairi M; Algabbani A; Alasiri A; Alhomaidan A; Alqahtani AS
Ther Innov Regul Sci; 2024 Jul; 58(4):689-695. PubMed ID: 38546962
[TBL] [Abstract][Full Text] [Related]
8. Combating counterfeit drugs.
Lancet; 2008 May; 371(9624):1551. PubMed ID: 18468523
[No Abstract] [Full Text] [Related]
9. Compounding pharmacy conundrum: "we cannot live without them but we cannot live with them" according to the present paradigm.
Guharoy R; Noviasky J; Haydar Z; Fakih MG; Hartman C
Chest; 2013 Apr; 143(4):896-900. PubMed ID: 23412546
[TBL] [Abstract][Full Text] [Related]
10. Quality of Medicines in Portugal: A Retrospective Review of Medicine Recalls (2000-2015).
Machado Reis AT; Berardo BFR; Loureiro R
PDA J Pharm Sci Technol; 2018; 72(1):44-49. PubMed ID: 29030530
[TBL] [Abstract][Full Text] [Related]
11. Reflections of the Angiotensin Receptor Blocker Recall by the FDA and Repercussions on Healthcare.
Gillette M; Taylor A; Butulija D; Kadiyala H; Jneid H
Cardiovasc Drugs Ther; 2020 Aug; 34(4):579-584. PubMed ID: 32318933
[TBL] [Abstract][Full Text] [Related]
12. A prescription for drug shortages.
Gehrett BK
JAMA; 2012 Jan; 307(2):153-4. PubMed ID: 22235084
[No Abstract] [Full Text] [Related]
13. Quality of medicines in Canada: a retrospective review of risk communication documents (2005-2013).
Almuzaini T; Sammons H; Choonara I
BMJ Open; 2014 Oct; 4(10):e006088. PubMed ID: 25361839
[TBL] [Abstract][Full Text] [Related]
14. Sterile compounding: clinical, legal, and regulatory implications for patient safety.
Qureshi N; Wesolowicz L; Stievater T; Lin AT
J Manag Care Spec Pharm; 2014 Dec; 20(12):1183-91. PubMed ID: 25443512
[TBL] [Abstract][Full Text] [Related]
15. As production goes global, drug supply faces greater risks to safety, quality.
Kuehn BM
JAMA; 2011 Aug; 306(8):811-3. PubMed ID: 21862736
[No Abstract] [Full Text] [Related]
16. [Trends in Non-prescription Drug Recalls in Japan].
Yamamoto C; Ishida T; Osawa T; Naito T; Kawakami J
Yakugaku Zasshi; 2016; 136(9):1307-12. PubMed ID: 27592833
[TBL] [Abstract][Full Text] [Related]
17. The Identification of Quality Risk Factors for Non-biological Complex Drugs and Epilepsy Drugs Using Statistical Analysis of Formulation-Based Recalls in the USA.
Kerstiens EA; Byrn SR; Clase KL
AAPS PharmSciTech; 2021 Dec; 23(1):19. PubMed ID: 34904204
[TBL] [Abstract][Full Text] [Related]
18. Manufacturer recalls commonly used painkiller amid fears of possible sabotage.
Ginn S
BMJ; 2011 Sep; 343():d5628. PubMed ID: 21893567
[No Abstract] [Full Text] [Related]
19. FDA embraces RFID to protect drug supply.
Young D
Am J Health Syst Pharm; 2004 Dec; 61(24):2612, 2615. PubMed ID: 15646694
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
